Objectives To compare registry and electronic health record (EHR) data mining approaches for cohort ascertainment in patients with pediatric pulmonary hypertension (PH) in an effort to overcome some of the limitations of registry enrollment alone in identifying patients with particular disease phenotypes.
A s with many rare diseases, the challenge of obtaining adequate sample sizes to study pediatric pulmonary hypertension (PH) has been addressed by enrolling patients into registries. 1, 2 However, registries are resource-intensive and can capture only patients who come to recruiters' attention. More recently, widespread adoption of electronic health records (EHRs) has allowed the mining of clinical data collected at the point of care to identify patients with particular disease phenotypes. 3, 4 Statistically derived "computable phenotypes," comprising a composite of varying EHR data elements, can accurately identify patients of interest in clinical data repositories. [5] [6] [7] [8] [9] [10] [11] [12] Our study had 2 primary objectives. First, we sought to compare 2 rare disease cohort ascertainment methods, a classic registry approach and mining of EHR data using a computable phenotype. Second, we examined the relative contribution of
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Methods
The goal of EHR-based cohort ascertainment is to identify patients with a high probability of having the phenotype of interest-in this case, PH-and thus who can be used as subjects for future studies without further clinician or researcher review. An overview of our EHR-based approach for cohort ascertainment is outlined in Figure 1 (available at www.jpeds .com). Beginning with the entire EHR database, we (1) created a candidate cohort of all possible patients with PH using broad criteria and extracted relevant COD and NLP features; (2) developed "computable phenotype" classification algorithms using a training set annotated with gold standard PH status; (3) applied these algorithms to all patients in the candidate cohort and validated the algorithms' predicted PH status using an independent test set of manually reviewed records; and (4) compared the cohort defined by the best-performing computable phenotype algorithm with a cohort enrolled in the traditional registry. The Institutional Review Board at Boston Children's Hospital approved the study protocol, which included informed consent for participation in the registry and waiver of informed consent for review and analysis of EHR data.
There were 2 main data sources for this study. The first was a traditional registry started by the Pediatric Pulmonary Hypertension Network (PPHNet) in 2014 (ClinicalTrials.gov: NCT02249923). 13 PPHNet is a multicenter pediatric registry enrolling new and established patients diagnosed with PH between birth and 18 years of age. Eligible patients were identified at Boston Children's Hospital beginning in October 2014 based on referral to the PH clinic or when the PH service was consulted during hospital admission. For the purposes of this study, only patients recruited to the PPHNet registry at Boston Children's Hospital were included. The second data source was the local Informatics for Integrating Biology and the Bedside (i2b2) 14 data warehouse at Boston Children's Hospital, which is part of the Scalable Collaborative for a Learning Health System network. 15 The i2b2 contains clinical data such as medication prescriptions, billing data including diagnostic codes, demographic data, and clinical notes.
A candidate cohort enriched in the phenotype of interestthat is, PH-was created to increase the positive predictive value for the subsequent machine learning algorithm given the rarity of PH in the general EHR population. Identification of the candidate cohort was designed to maximize sensitivity for capturing appropriate patients. We included patients with potential pediatric PH based on diagnostic codes and medications in i2b2. Patients with at least 1 International Classification of Diseases, Ninth Revision (ICD-9) code related to pulmonary vascular disease or persistent fetal circulation (416.0, 416.8, 416.9, and 747.83) were added. Also included were patients who were prescribed or had recorded in their medication history at least 1 of the following medications used to treat pediatric PH: ambrisentan, bosentan, epoprostenol, iloprost, sildenafil, tadalafil, and treprostinil. Analysis was limited to patients with relevant ICD-9 codes or medications documented after January 1, 2013, to minimize the capture of patients no longer followed at our institution for PH. The EHR candidate cohort consisted of 3494 patients, of whom 3205 had notes. One patient's PH status could not be determined on chart review, and this patient was excluded from further analysis.
For each patient in the candidate cohort, we queried i2b2 for diagnoses and procedures known to be associated with pediatric PH. We also included diagnoses in which right ventricular (RV) hypertension led to inaccurate coding of PH. Fyler codes, which define a taxonomy of congenital heart disease and related concepts, 16 were available from the Department of Cardiology database at the study institution. Fyler codes for PH and RV hypertension were incorporated into the dataset. We refer to COD data, excluding Fyler codes, as "standard codified data," to distinguish it from domain-specific coding. Indicators of healthcare utilization were created by calculating the total number of ICD-9 codes for each patient. Table I (available at www.jpeds.com) shows the features extracted. Features present in <5% of patients were dropped from further analysis.
To include narrative data in the EHR as features for the development of a computable phenotype of PH, we used NLP to identify concepts relevant to PH in patients' clinical notes. Review articles of PH 17, 18 and notes of sample patients with and without PH were used to create a dictionary of clinical concepts relevant to PH. We processed these sources using the Narrative Information Linear Extraction (NILE) package, 19, 20 which includes a named entity recognition package that extracts terms and maps them to clinical concepts using the Unified Medical Language System. 21 The final dictionary consisted of 137 concepts, including all concepts appearing in both review articles and notes and additional concepts selected by a clinician (A.G.) that appeared in either the articles or notes, but not both. Clinical notes, including inpatient progress notes, discharge summaries, and outpatient clinic notes, for the patients identified in the candidate cohort were then processed using NILE to search for the 137 PH dictionary concepts. We dropped 79 concepts appearing in fewer than 5% of notes that mentioned PH. Of 211 806 notes for patients in the candidate cohort, 181 524 eligible notes with length >500 characters were used for analysis. Each note was annotated with the number of times that each dictionary concept appeared in that note, and the total number of mentions for each concept in all clinical notes of each patient were used for candidate NLP features. The list of concepts used is presented in Table I .
We randomly selected 242 patients from the candidate cohort to create a training set. We initially reviewed 250 patients; 7 were subsequently found not to have had a PH-related diagnosis or medication recorded after January 1, 2013, as specified in our inclusion criteria, and were excluded from further analysis. An additional patient's PH status could not be determined from chart review, as noted above, and this patient was also excluded from further analysis. A single physician (A.G.) manually reviewed the medical records for the remaining Volume 188 • September 2017 242 patients using a structured case report form to determine the gold standard PH status for these patients. A second physician (M.P.M.) reviewed 50 of these charts to establish interrater reliability, which was 92%. Discordant classification was resolved by consensus.
Clinicians used the following criteria to determine PH status during manual review of the medical records. We considered cardiac catheterization, when available, the gold standard for a diagnosis of PH when thresholds of mean distal pulmonary arterial pressure ≥25 mm Hg and indexed pulmonary vascular resistance ≥3 Wood units/m 2 were met. When catheterization data were not available, we used echocardiographic evidence of elevated RV pressure (ie, estimates of RV pressure based on tricuspid regurgitation jet, gradient across a ventricular septal defect or patent ductus arteriosus, or ventricular septal configuration) without evidence of RV outflow tract obstruction (RVOTO) to classify a patient as having PH. When RVOTO was present, a patient without catheterization evidence of PH was presumed to not have PH. In cases of unrestrictive leftto-right shunts, if evidence of elevated RV pressure did not persist at least 6 months after repair of the shunt, then the patient was presumed to have elevated RV pressure secondary to the unrestrictive lesion and not PH. Patients with only single echocardiograms showing elevated RV pressure within the first 3 days of life, without other documentation of follow-up for PH or with documented subsequent resolution of PH, were considered to not have PH, to exclude patients with transitional circulation but include patients with persistent PH of the newborn.
The total number of COD and NLP candidate features was large relative to the size of the training set. Therefore, to reduce overfitting, we first used the automated feature extraction for phenotyping procedure to reduce the number of candidate features. 20 With the automated feature extraction for phenotyping procedure, features were included in model estimation if their absolute correlation with the NLP variable for mention of "primary pulmonary hypertension" and with ICD-9 codes for other chronic pulmonary heart diseases (416.8) or persistent fetal circulation (747.83) exceeded 0.2 (Table II; available at www.jpeds.com). All models also included the ICD-9 codes used to obtain the candidate cohort and the total number of ICD-9 codes for the patient to adjust for healthcare utilization.
To predict the probability of having PH, we used the glmpath package 22 to fit adaptive least absolute shrinkage and selection operator penalized logistic regression models 23 to the training data, with the response being the gold standard PH status and predictors being COD features only (model 1) or both COD and NLP features (model 2). The penalized regression reduces overfitting and simultaneously performs variable selection. The tuning variable was selected based on a modified Bayes information criterion. 24, 25 We also estimated models 1 and 2 excluding Fyler codes, which are not available at all institutions, for a total of 4 algorithms. Count data, which tended to be highly skewed, were log-transformed and all features were standardized to have unit variance before model fitting. Because NLP data were not available for all patients, the models including NLP features were trained with the 224 patients in the training set with narrative information. The predicted probabilities of PH for patients who did not have narrative information were obtained with the corresponding COD models.
Receiver operating characteristic analysis was conducted with the training set to determine an appropriate threshold for classifying PH status. Overfitting bias was corrected for using the 0.632 bootstrap procedure. 26, 27 To tune the algorithm for high positive predictive value, the threshold probability was selected to achieve 95% specificity. Each algorithm was applied to the patients in the candidate cohort (including to the 242 patients used for model training), and subjects with predicted probabilities exceeding the estimated threshold were classified as having PH.
The performance of the 4 computable phenotype algorithms was further validated using an additional 136 randomly selected patients (150 patients were initially sampled, of whom 12 were registry patients and 2 were sampled twice) from the candidate cohort whose gold standard PH status was determined by a single physician (A.G.). Also included for validation were the 179 patients with PH who had been enrolled in the traditional registry at the study institution at the time of data extraction. Inverse probability weighting was used to correct for the nonrandom inclusion of these validation samples. Standard error estimates were obtained with the standard bootstrap with 500 replicates.
To determine the number of eligible patients identified by the computable phenotype algorithm who were not identified in the registry, we selected patients from those predicted to have PH by the best-performing computable phenotype algorithm. To maximize the validity of the comparison for prospective patient enrollment, selected EHR patients were matched to registry eligibility criteria of PH diagnosis before age 19 years and presentation at the study institution after October 28, 2014, the initial date of recruitment for the PPHNet registry. These criteria thus avoided an invalid comparison between the PPHNet registry patients and EHR patients with adult-onset PH seen at our institution (typically adults with congenital heart disease), and also avoided counting historical PH patients who were no longer followed at our hospital and thus could not have been recruited to the PPHNet registry.
We compared the patients identified by computable phenotype and those included in the registry across demographic and clinical variables. Diagnoses were determined based on ICD-9 billing codes for patients, and only diagnostic codes present in at least 5% of the cohort were included. The computable phenotype and registry cohorts were compared using the Student t test for continuous variables and the Fisher exact test for categorical variables. A P value < .05 was considered statistically significant. Analyses were performed using R version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria). 28 
Results
As of October 9, 2015, 179 patients with PH were enrolled in the PPHNet registry at our institution. An additional 55 THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 188 patients had been screened for participation in the registry but were not enrolled, due to either not meeting inclusion criteria or informed consent not being given. The prevalence of PH among the 242 patients reviewed to create the gold standard training dataset was 38%. After frequency control, the initial set of candidate features included a total of 24 COD features and 57 NLP features. After automated feature selection, a total of 23 features (9 COD, including 1 domainspecific Fyler code, and 14 NLP) were included in the candidate set for model estimation ( Table II) . The most influential features-those with the most positive or negative coefficient values-in the computable phenotype algorithms are shown in Table III (available at www.jpeds.com). COD variables that were inversely associated with PH (ie, tetralogy of Fallot, pulmonary valve or subpulmonic stenosis, pulmonary atresia, or transposition of the great arteries) were not influential if NLP variables were included in the computable phenotype algorithm.
Compared with the 179 patients enrolled in the registry at our institution at the time of data analysis, the best computable phenotype model derived using EHR data identified 413 patients who might have been eligible for the registry but were not enrolled ( Figure 2 and Table IV; Figure 2 available at www.jpeds.com). An additional 151 patients with pediatric PH were identified by the algorithm but were not seen at the study institution after the start of recruitment for the PPHNet registry. The computable phenotype algorithm also identified 300 patients whose first PH-related diagnosis or medication was documented after age 19 years. Of the 179 registry patients, 162 (91%) were correctly classified as having PH by the computable phenotype algorithm. Addition of Fyler codes and NLP features to the models increased the sensitivity from 48% for COD data without Fyler codes to 66%. Models including either Fyler codes or NLP had a similar area under the receiver operating characteristic curve of 89%, and the area under the receiver operating characteristic curve with all data types included was 90%.
The patients identified by the computable phenotype algorithm but not captured in the registry were younger than the registry patients (7.8 ± 10.9 years vs 9.2 ± 8.1 years; P < .001) and included a higher proportion of deceased patients (7% [n = 29] vs 3% [n = 5]; P = .05) ( Table V) . A higher proportion of registry patients had congenital diaphragmatic hernia (CDH), reflecting the institutional practice of referring all CDH patients to the PH clinic. Patients in the registry appeared to be more medically complex, with a greater number of hospital visits and number of diagnoses per patient. Finally, we noted differences in PH coding practices; a higher proportion of computable phenotype patients not in the registry had "persistent fetal circulation" billed (30% [n = 122] vs 15% [n = 27]; P < .001), whereas "primary pulmonary hypertension," "other chronic pulmonary heart disease," and "chronic pulmonary heart disease, unspecified," were more commonly billed for patients in the registry (P < .01 for each; Figure 3 , available at www.jpeds.com). Inclusion of the 151 patients identified by the computable phenotype but not seen at the study institution after commencement of registry recruitment did not significantly alter these results, with the exception of an even higher proportion of deceased patients (12%; 65 of 564; P < .001).
We compared high-frequency diagnoses between the cohorts identified by the computable phenotype and by the registry. When comparing the computable phenotype patients and registry patients, 2 patterns of greater disease prevalence emerged: congenital and acquired heart disease, including mitral valve disease and heart failure; and neonatal distress, including meconium aspiration and respiratory distress syndrome (Figure 4) . Gastrointestinal disease and malformations, chronic respiratory disease (including CDH, obstructive sleep apnea, asthma, and machine dependence), prematurity, developmental disorders, and seizures were 1.7-2.4 times more frequent among New patients refers to patients identified by the computable phenotype algorithm but not enrolled in the registry.
the patients enrolled in the registry than among those identified by computable phenotype (Figure 5 ).
Discussion
In this study, an EHR-based computable phenotype identified a pediatric PH cohort more than 3-fold larger than a traditional disease registry. Notably, the 2 populations were phenotypically different, demonstrating that certain patient populations are not captured effectively by the registry. Thus, we have demonstrated the utility of cohort ascertainment through EHR mining for powering future studies of pediatric PH by directly comparing the cohorts using computable phenotypes versus a traditional registry. Traditional patient registries have been useful for the study of rare diseases, 29 
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Pulmonary Hypertension registry enrolled 456 pediatric patients, of whom 362 had confirmed PH. 2 In contrast, at a single institution, application of a computable phenotype to EHR data identified 575 patients with PH.
Registry-based cohorts may be limited if not all patients of interest are seen in the enrolling clinics or by the enrolling services, as occurred in our patient population. The PPHNet registry is recruiting patients seen by PH specialists, but such a referral was not made for many of the patients identified only by the computable phenotype algorithm. Many of these patients might not come to the attention of PH specialists because their PH resolves with age, as evidenced by the increased relative frequency of neonatal diagnoses associated with PH in EHR versus registry patients, and by the fact that "persistent fetal circulation" is more likely to be assigned as the diagnostic code for patients in the EHR cohort. These patients are expected to Figure 5 . ICD-9 codes with greater relative frequency among registry patients compared with patients identified only in the EHR. Magenta lines indicate ICD-9 codes related to gastrointestinal disease and malformations, blue lines indicate ICD-9 codes related to chronic respiratory disease, and green lines indicate ICD-9 codes related to prematurity, developmental disorders, and seizures. Trivial diagnoses are shown in light gray to emphasize diagnoses of interest. Only conditions with P < .05 are shown. Some ICD-9 code descriptions appear twice due to unique ICD-9 codes mapping to similar descriptions.
be important for understanding the natural history and pathophysiology of persistent PH of the newborn. Another group of patients that was relatively overrepresented in the computable phenotype cohort was the group with diagnoses of left heart disease. We suspect that many of these patients, in whom PH was not the primary pathophysiology but rather was secondary pathophysiology, were being managed by their primary cardiologists and thus did not come to a PH specialist's attention. This has the potential to lead to ascertainment bias in registry-based studies when recruitment is dependent on patients being referred to disease specialists. Finally, some patients who were identified through screening as candidates for inclusion in the PPHNet registry could not be approached by recruiters, or their families declined to give consent. Nonetheless, these patients can be identified by a computable phenotype and followed in an EHR-based cohort based on clinical data routinely collected at the point of care. These complementary benefits of an EHR-based approach to cohort ascertainment allow more complete patient capture, which is particularly important for rare diseases and for particular patient subpopulations that may be more difficult to recruit to traditional registries.
Similar to previous efforts in this domain, 3 developing a computable phenotype for PH faces the challenge of a complex disorder with unique determinants of disease state that often are confounded by similar traits not indicative of the disease of interest. In particular, we found that RV hypertension often, but not always, led to inaccurate coding of PH in billing codes. Most, but not all, patients with RVOTO who had an ICD-9 code related to PH had RV hypertension but did not actually have PH. Thus, rules-based approaches are either overly broad or narrow. More sophisticated, statistically derived computable phenotypes allowed us to obtain algorithms with adequate sensitivity and specificity. In such algorithms, diagnoses such as those associated with RVOTO were inversely associated with PH in the computable phenotype models that did not include NLP variables. By incorporating data contained in expert clinicians' notes, the models including NLP-derived variables did not rely on these billing codes to achieve adequate performance, demonstrating the utility of NLP in overcoming some of the limitations of claims data. Domainspecific coding systems, such as Fyler codes, also helped overcome such limitations. Similar performance might be achieved using carefully curated problem lists or other specific annotations by domain experts.
Like other studies of EHR data, this study has several inherent limitations. Although the best-performing algorithm achieved a positive predictive value of 85%, misclassification of PH status may lead to slight bias in the results of analyses of this cohort. This work was performed at a single institution, and institution-specific coding and documentation practices may affect the generalizability of this computable phenotype to other institutions. Finally, our current computable phenotype algorithm relies on ICD-9 codes, which were recently replaced with ICD-10 in the US. Given that the 4 ICD-9 codes used for cohort definition in the present study can be mapped to 6 ICD-10 codes, and that coding practices likely will differ across institutions, further work is needed to adapt the present algorithm to allow ongoing patient recruitment based on EHR data across sites.
In this study, we identified patients retrospectively based on computable phenotype, but the EHR-based approach used here provides the backbone for a prospective approach to ongoing patient recruitment. Based on the queried i2b2 database, which is continually updated with new patient data, the computable phenotype can continue to identify new patients for recruitment into future studies. Furthermore, the predicted status of having or not having PH can be incorporated as a "fact" into i2b2, creating a permanent notation for identifying patients for research purposes outside the scope of the current project. These facts can be validated and integrated with other data, including registry data and textual information in notes processed by NLP, using knowledge management pipelines such as tranSMART. 30 Thus, by integrating traditional registry information with patient identification and phenotyping based on EHR data, we can create a sustainable infrastructure to significantly grow the number of patients and amount of data available for pediatric PH research.
EHR-and registry-based methods of patient recruitment are complementary, with a registry infrastructure allowing collection of detailed phenotypic information and an EHRbased computable phenotype expanding the breadth of patient recruitment, including patient subtypes not included in the registry. The computable phenotype infrastructure allows for scalable, ongoing patient identification not only at the study institution, but also, if the algorithm is validated, at other centers caring for pediatric PH. Using these methods, we anticipate recruiting the largest cohort of pediatric PH patients to date for research on this rare, highly morbid disorder. ■ Figure 3 . Comparison of ICD-9 coding practices between the computable phenotype and registry cohorts. Bars represent percentage of patients who had each ICD-9 code recorded at least once. ****P < .0001, ***P < .001, **P < .01 for pairwise comparisons between cohorts. Features with a correlation of at least 0.2 with both one of the ICD-9 codes and with the NLP variable for primary PH are shown in bold type, as are the ICD-9 codes used to create the candidate cohort and the total number of ICD-9 codes, which were included in all models. Textual features derived from natural language processing are preceded by "NLP," and Fyler codes are preceded by "Fyler." 
